OSUR OraSure Technologies Inc

OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the 2008 UBS Global Life Sciences Conference in New York City at approximately 2:30pm Eastern Time, (11:30am Pacific Time) on Tuesday, September 23, 2008. The conference will be simultaneously webcast over the Internet. Interested investors can access the live audio webcast of the discussion by going to OraSure Technologies� web site, www.orasure.com, and clicking on the Investor Information link. A replay of the audio webcast will be available until, September 30, 2008, on OraSure Technologies� web site. About OraSure Technologies OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians� offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV. In addition, the Company supplies oral-fluid testing solutions for drugs of abuse testing. For more information on the Company, please go to www.orasure.com.